Sio Gene Therapies Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • 2PO

  • Latest Deal Amount
  • $40M

Sio Gene Therapies General Information

Description

Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis.

Contact Information

Website
www.siogtx.com
Formerly Known As
Roivant Neurosciences, Axovant Gene Therapies, Axovant Gene Therapies Ltd., Roivant Neurosciences Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 130 West 42nd Street
  • 26th floor
  • New York, NY 10036
  • United States
+1 (877)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Corporate Office
  • 130 West 42nd Street
  • 26th floor
  • New York, NY 10036
  • United States
+1 (877)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sio Gene Therapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. 2PO 15-Mar-2019 $40M Completed Clinical Trials - Phase 3
4. 2PO 17-Dec-2018 Completed Clinical Trials - Phase 3
3. Debt - General 02-Feb-2017 Completed Clinical Trials - Phase 3
2. IPO 11-Jun-2015 $315M $315M Completed Clinical Trials - Phase 3
1. Early Stage VC Completed Startup
To view Sio Gene Therapies’s complete valuation and funding history, request access »

Sio Gene Therapies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The c
Other Pharmaceuticals and Biotechnology
New York, NY
12 As of 2022

Coral Gables, FL
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sio Gene Therapies Competitors (11)

One of Sio Gene Therapies’s 11 competitors is Catalyst Pharmaceuticals, a Corporate Backed or Acquired company based in Coral Gables, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Catalyst Pharmaceuticals Corporate Backed or Acquired Coral Gables, FL
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
Moderna Formerly VC-backed Cambridge, MA
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Scynexis Formerly VC-backed Jersey City, NJ
You’re viewing 5 of 11 competitors. Get the full list »

Sio Gene Therapies Patents

Sio Gene Therapies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023004365-A1 Vector constructs for delivery of nucleic acids encoding therapeutic proteasome activator complex subunits and methods of using the same Inactive 20-Jul-2021
EP-3937985-A1 Gene therapy compositions and methods for treating parkinson's disease Inactive 10-Mar-2019
US-20220175962-A1 Gene therapy compositions and methods for treating parkinson's disease Inactive 10-Mar-2019
WO-2020183374-A1 Gene therapy compositions and methods for treating parkinson's disease Inactive 10-Mar-2019
US-20190046506-A1 Use of 5ht2a inverse agonists for treating psychosis Inactive 10-Aug-2017 A61K31/415
To view Sio Gene Therapies’s complete patent history, request access »

Sio Gene Therapies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sio Gene Therapies ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Sio Gene Therapies’s complete esg history, request access »

Sio Gene Therapies FAQs

  • When was Sio Gene Therapies founded?

    Sio Gene Therapies was founded in 2014.

  • Where is Sio Gene Therapies headquartered?

    Sio Gene Therapies is headquartered in New York, NY.

  • What is the size of Sio Gene Therapies?

    Sio Gene Therapies has 12 total employees.

  • What industry is Sio Gene Therapies in?

    Sio Gene Therapies’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Sio Gene Therapies a private or public company?

    Sio Gene Therapies is a Private company.

  • What is Sio Gene Therapies’s current revenue?

    The current revenue for Sio Gene Therapies is .

  • How much funding has Sio Gene Therapies raised over time?

    Sio Gene Therapies has raised $440M.

  • Who are Sio Gene Therapies’s competitors?

    Catalyst Pharmaceuticals, ACADIA Pharmaceuticals, Moderna, Alnylam Pharmaceuticals, and Scynexis are some of the 11 competitors of Sio Gene Therapies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process